Maxim Group Downgrades Mast Therapeutics (MSTX) to Hold Following Vepoloxamer Phase 3 Miss
Go back to Maxim Group Downgrades Mast Therapeutics (MSTX) to Hold Following Vepoloxamer Phase 3 Miss| MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) | Delayed: 8.57 +0.38 (4.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.19 | 52 Week High | $0.71 | |||
| Open | $8.15 | 52 Week Low | $0.07 | |||
| Day High | $8.87 | P/E | N/A | |||
| Day Low | $8.07 | EPS | $-0.35 | |||
| Volume | 9,812,913 | |||||
